We have identified opportunities with Ultomiris/Soliris REMS requirements, noteably with:
• Meningococcal vaccine series prior to administration, booster after 1 year, and every 2-3 years after
• Antimicrobial prophylaxis required if above not met
We are interested to see what other sites are doing to ensure compliance.
Thanks!
Maria Cumpston, PharmD, CPPS
Medication Safety Officer & Compliance Director
WVU Hospitals
304-598-4000 ext 73356